They will often improve as lupus is adequately controlled and their reappearance is often the first indicator of a disease flare
Once you have reached the maintenance dose, you can continue to take the medication long-term
Switching between GLP1 receptor agonists in clinical practice: Expert consensus and practical guidance
A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study was done to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of orforglipron
Drawing on health records from Ontario, Canada, researchers at the University of Toronto analyzed nearly 140,000 adults with type 2 diabetes to investigate a possible link between GLP-1 use and wet AMD